The introduction of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable interest within the weight loss community. This groundbreaking dual GIP and GLP-1 target medication appears to provide notable improvements in weight loss compared to previous therapies. Early clinical trials hav